141 related articles for article (PubMed ID: 10329611)
1. Mast cell granule heparin proteoglycan induces lacunae in confluent endothelial cell monolayers.
Lagunoff D; Rickard A
Am J Pathol; 1999 May; 154(5):1591-600. PubMed ID: 10329611
[TBL] [Abstract][Full Text] [Related]
2. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
3. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
Lindstedt L; Lee M; Kovanen PT
Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
[TBL] [Abstract][Full Text] [Related]
4. Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules.
Kokkonen JO; Kovanen PT
Biochem J; 1987 Jan; 241(2):583-9. PubMed ID: 3593208
[TBL] [Abstract][Full Text] [Related]
5. Mast cell exocytosis: evidence that granule proteoglycan processing is not coupled to degranulation.
Ruoss SJ; Gold WM; Caughey GH
Biochem Biophys Res Commun; 1991 Aug; 179(1):140-6. PubMed ID: 1909118
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and microscopic evidence for the internalization and degradation of heparin-containing mast cell granules by bovine endothelial cells.
Atkins FM; Friedman MM; Metcalfe DD
Lab Invest; 1985 Mar; 52(3):278-86. PubMed ID: 3974200
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.
Paananen K; Kovanen PT
J Biol Chem; 1994 Jan; 269(3):2023-31. PubMed ID: 8294453
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: identification of heparin as a granule-associated suppressor factor.
Frieri M; Metcalfe DD
J Immunol; 1983 Oct; 131(4):1942-8. PubMed ID: 6413584
[TBL] [Abstract][Full Text] [Related]
9. Mast cell granule-mediated uptake of low density lipoproteins by macrophages: a novel carrier mechanism leading to the formation of foam cells.
Kovanen PT
Ann Med; 1991; 23(5):551-9. PubMed ID: 1756025
[TBL] [Abstract][Full Text] [Related]
10. Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.
Atkins FM; Metcalfe DD
J Immunol; 1983 Sep; 131(3):1420-5. PubMed ID: 6886421
[TBL] [Abstract][Full Text] [Related]
11. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation.
Benitz WE; Kelley RT; Anderson CM; Lorant DE; Bernfield M
Am J Respir Cell Mol Biol; 1990 Jan; 2(1):13-24. PubMed ID: 2137707
[TBL] [Abstract][Full Text] [Related]
12. Mast cell granules cause proliferation of human microvascular endothelial cells.
Marks RM; Roche WR; Czerniecki M; Penny R; Nelson DS
Lab Invest; 1986 Sep; 55(3):289-94. PubMed ID: 2427796
[TBL] [Abstract][Full Text] [Related]
13. Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture.
Wang Y; Kovanen PT
Circ Res; 1999 Jan 8-22; 84(1):74-83. PubMed ID: 9915776
[TBL] [Abstract][Full Text] [Related]
14. Secretory granule proteoglycans of mast cells and natural killer cells.
Stevens RL
Ciba Found Symp; 1986; 124():272-85. PubMed ID: 3816420
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of intracellular proteoglycans.
Metcalfe DD; Austen KF
Monogr Allergy; 1979; 14():236-48. PubMed ID: 388198
[TBL] [Abstract][Full Text] [Related]
16. Preparative purification of the rat mast cell chymase: characterization and interaction with granule components.
Yurt R; Austen KF
J Exp Med; 1977 Nov; 146(5):1405-19. PubMed ID: 336834
[TBL] [Abstract][Full Text] [Related]
17. Enzymes of the mast cell granule.
Schwartz LB; Austen KF
J Invest Dermatol; 1980 May; 74(5):349-53. PubMed ID: 6771334
[TBL] [Abstract][Full Text] [Related]
18. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro.
Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Bloes WF; Stevens RL
J Immunol; 1985 Nov; 135(5):3454-62. PubMed ID: 2413121
[TBL] [Abstract][Full Text] [Related]
19. Mast cell chymase in complex with heparin proteoglycan is regulated by protamine.
Pejler G
FEBS Lett; 1996 Apr; 383(3):170-4. PubMed ID: 8925890
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways in mast cell granule-mediated endothelial cell activation.
Chi L; Stehno-Bittel L; Smirnova I; Stechschulte DJ; Dileepan KN
Mediators Inflamm; 2003 Apr; 12(2):79-87. PubMed ID: 12775357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
